Potomac Capital Management’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
Potomac Capital Management's ATEX Position: Q3 2026 in Review
Potomac Capital Management reduced its Anterix (ATEX) stake by 18% in Q3 2026, selling an estimated $2.55M and leaving 127,386 shares worth $10M. The position accounts for 7.74% of the portfolio, ranked #2.
Potomac Capital Management first reported a position in ATEX in Q4 2025 and has held it in 4 quarters since. The position peaked at $16M in Q2 2026. 177 funds tracked by Wall St. Rank hold ATEX as of Q3 2026.
- Potomac Capital Management held 127,386 shares of Anterix worth $10M as of Q3 2026.
- Potomac Capital Management sold 27,685 Anterix shares in Q3 2026, an estimated $2.55M.
- Anterix made up 7.74% of Potomac Capital Management's portfolio in Q3 2026, its #2 holding.
- Potomac Capital Management first reported a position in Anterix in Q4 2025 and has held it in 4 quarters since.
- Potomac Capital Management's Anterix position peaked at $16M in Q2 2026.
- 177 funds tracked by Wall St. Rank held Anterix as of Q3 2026.
Based on Potomac Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.